Apr 17, 2025 9:15am EDT bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
Mar 26, 2025 9:00am EDT Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
Mar 19, 2025 9:00am EDT Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence
Mar 13, 2025 9:00am EDT Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer
Mar 06, 2025 8:00am EST bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth
Feb 26, 2025 11:30am EST bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million
Feb 25, 2025 9:58am EST bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million
Jan 22, 2025 8:00am EST bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
Jan 13, 2025 8:00am EST bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung
